A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...

The rise of appetite-suppressing drugs like Ozempic is changing the way Americans eat, but there's a twist: cannabis ...

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

More than one-third of websites selling their own versions implied the products were the same as the FDA-approved drugs.